These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 11503503

  • 1. [Labile blood products and their preparation].
    Chabanel A, Folléa G.
    Rev Prat; 2001 Jun 30; 51(12):1306-10. PubMed ID: 11503503
    [Abstract] [Full Text] [Related]

  • 2. National French observatory of the quality of blood components for transfusion.
    Chabanel A, Masse M, Begue S, EFS group of blood component QC laboratory managers.
    Transfus Clin Biol; 2008 Jun 30; 15(3):85-90. PubMed ID: 18524661
    [Abstract] [Full Text] [Related]

  • 3. [Experiences with autologous donation and transfusion equipment].
    Mehrkens HH, Geiger P, Weindler M, Wollinsky KH, Pohland H.
    Beitr Infusionsther; 1991 Jun 30; 28():274-82. PubMed ID: 1725638
    [Abstract] [Full Text] [Related]

  • 4. [Indications for labile blood products].
    Jeanne M, Rasonglès P.
    Rev Prat; 2001 Jun 30; 51(12):1318-27. PubMed ID: 11503505
    [Abstract] [Full Text] [Related]

  • 5. [Techniques of preparation and indications of labile blood products].
    Clément S.
    Transfus Clin Biol; 2011 Apr 30; 18(2):250-61. PubMed ID: 21474355
    [Abstract] [Full Text] [Related]

  • 6. Pathogen reduction of blood components.
    Solheim BG.
    Transfus Apher Sci; 2008 Aug 30; 39(1):75-82. PubMed ID: 18602343
    [Abstract] [Full Text] [Related]

  • 7. [Essential standards of mechanical autologous donation and transfusion].
    Paravicini D.
    Beitr Infusionsther; 1991 Aug 30; 28():341-7. PubMed ID: 1725652
    [Abstract] [Full Text] [Related]

  • 8. [Quality control in autologous blood donation and transfusion].
    Dietrich G, Kretschmer V.
    Beitr Infusionsther; 1991 Aug 30; 28():348-55. PubMed ID: 1725653
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The transfusion chain: from donor to recipient].
    Beauplet A.
    Rev Prat; 2001 Jun 30; 51(12):1294-8. PubMed ID: 11503501
    [Abstract] [Full Text] [Related]

  • 12. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG, Seghatchian J.
    Transfus Apher Sci; 2006 Aug 30; 35(1):83-90. PubMed ID: 16934528
    [Abstract] [Full Text] [Related]

  • 13. [Checking of blood product in hospital].
    Girard A.
    Transfus Clin Biol; 2004 Oct 30; 11(4):205-9. PubMed ID: 15564102
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients.
    Karger R, Stangenberg K, Hinrichs F, Griss P, Kretschmer V.
    Transfus Med; 2004 Oct 30; 14(5):347-57. PubMed ID: 15500454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Implementation of an effective program for quality assurance and quality control in living cell therapy: a 2-year experience with autolymphocyte therapy.
    du Moulin GC, Liu V, Osband ME.
    Transplant Proc; 1992 Dec 30; 24(6):2803-8. PubMed ID: 1465947
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.